首页> 外国专利> Use of a thromboxane - a2 - receptor antagonist for the manufacture of a arzeneimittels for treating pulmonary hypertension, which, by means of a protamine - induced neutralization of heparin is caused.

Use of a thromboxane - a2 - receptor antagonist for the manufacture of a arzeneimittels for treating pulmonary hypertension, which, by means of a protamine - induced neutralization of heparin is caused.

机译：血栓烷-a2-受体拮抗剂在制备治疗肺动脉高压的arzeneimittels中的用途，所述arzeneimittels通过鱼精蛋白诱导的肝素中和作用。

页面导航

摘要
著录项
相似文献

摘要

A method is provided for preventing, reducing or reversing adverse reactions, such as pulmonary hypertension produced when protamine interacts with heparin, by administering a thromboxane A2 receptor antagonist.

机译：提供了通过施用血栓烷A 2受体拮抗剂来预防，减少或逆转诸如鱼精蛋白与肝素相互作用时产生的肺动脉高压等不良反应的方法。

著录项

公开/公告号DE68907976T2

专利类型
公开/公告日1994-03-31

原文格式PDF
申请/专利权人 SQUIBB & SONS INC US;
展开▼

申请/专利号DE1989607976T
发明设计人 OGLETREE MARTIN L US;GROVER GARY J US;SCHUMACHER WILLIAM A US;FRIEDHOFF LAWRENCE T US;
展开▼

申请日1989-04-10
分类号A61K31/557;A61K31/00;A61K31/19;
国家 DE
入库时间 2022-08-22 04:35:24

相似文献

专利
外文文献
中文文献